Safety and Effectiveness of Abatacept in a Prospective Cohort of Patients with Rheumatoid Arthritis–Associated Interstitial Lung Disease

Objective: To prospectively evaluate the safety and efficacy profile of abatacept in patients with rheumatoid arthritis–associated interstitial lung disease (RA-ILD). Methods: We performed a prospective observational multicenter study of a cohort of patients with RA-ILD treated with abatacept betwee...

Descrición completa

Detalles Bibliográficos

Principais autores:	Natalia Mena-Vázquez, Marta Rojas-Gimenez, Clara Fuego-Varela, Aimara García-Studer, Nair Perez-Gómez, Carmen María Romero-Barco, Francisco Javier Godoy-Navarrete, Sara Manrique-Arija, Myriam Gandía-Martínez, Jerusalem Calvo-Gutiérrez, Pilar Morales-Garrido, Coral Mouriño-Rodriguez, Patricia Castro-Pérez, Isabel Añón-Oñate, Francisco Espildora, María Carmen Aguilar-Hurtado, Ana Hidalgo Conde, Rocío Arnedo Díez de los Ríos, Eva Cabrera César, Rocío Redondo-Rodriguez, María Luisa Velloso-Feijoo, Antonio Fernández-Nebro
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2022-06-01
Series:	Biomedicines
Assuntos:	rheumatoid arthritis interstitial lung disease biologics abatacept
Acceso en liña:	https://www.mdpi.com/2227-9059/10/7/1480
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!